ArticleBiology direct2026
PLIN3 overexpression in lung adenocarcinoma promotes M2 macrophage-myofibroblast transition in the tumor microenvironment.
Article in Biology direct, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundMacrophage–myofibroblast transition (MMT) promotes tumor progression. Studies have primarily emphasized macrophage-intrinsic regulation; however, whether lung adenocarcinoma (LUAD) cells actively drive MMT in tumor-associated macrophages (TAMs) remains unclear.
methodsWe integrated LUAD single-cell RNA sequencing (scRNA-seq) and bulk transcriptomic datasets, applying MMT-infiltration-stratified differential analysis to identify tumor cell-derived upstream regulators of MMT. Multiple machine learning algorithms were used to construct an MMT-related risk score. SHAP analysis prioritized key genes, and NicheNet inferred tumor–macrophage ligand–receptor–target axes. Tumor cell–conditioned medium (CM)–driven MMT induction in M2 macrophages was examined by dual immunofluorescence and in vitro experiments.
resultsSingle-cell analysis showed that M2 macrophages in LUAD exhibit variable activation of an MMT-related transcriptional program. Tumor-level differential analysis across MMT infiltration strata identified tumor cell-derived candidate regulators of MMT. A 9-gene MMT prognostic risk model was established using univariate Cox regression and machine learning analyses. This model achieved a higher C-index than previously reported models, and high-risk tumors displayed an immunosuppressive infiltration pattern. SHAP analysis identified PLIN3 as a key driver. NicheNet analysis suggested that PLIN3-high tumor cells may induce MMT through TGF-β1-related signaling. Immunohistochemistry demonstrated PLIN3 upregulation in LUAD tissues, while immunofluorescence further revealed enrichment of CD68⁺α-SMA⁺ macrophages around tumor cells in PLIN3-high samples. LUAD cell-derived CM induced MMT in M2 macrophages. PLIN3 knockdown in LUAD cells attenuated CM-induced MMT, whereas PLIN3 overexpression enhanced it. PLIN3 knockdown also suppressed LUAD cell migration, invasion, and colony formation.
conclusionHigh PLIN3 expression in LUAD promotes MMT through tumor–macrophage crosstalk in the tumor microenvironment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.